Sysmex Europe
Flow Cytometry

The IVDR and transitional timelines - implications for clinical flow cytometry laboratories

The IVDR (Regulation (EU) 2017/746 on in vitro diagnostic medical devices) will have major consequences for the diagnostic sector, and especially for flow cytometry laboratories that perform in-house tests (also known as Laboratory Developed Tests, or LDTs).

Although the recent amendment does not alter any of the requirements of the regulation, it does change the date upon which some requirements will come into effect for certain IVD assays, including LDTs. Understanding these changes and preparing accordingly will be key to safeguarding the continuity of diagnostic services in laboratories.

Course target group

This webinar is recommended for lab managers, lab technicians, quality officers and quality managers.

Back to list



Copyright © Sysmex Europe SE. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.